Sudhin Thayyil
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sudhin Thayyil has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Anil Gupta
Department of Paediatrics and Chemical Pathology, University Hospital of North Tees and Hartlepool, UK
1 shared publicationIan G. Verber
Department of Paediatrics and Chemical Pathology, University Hospital of North Tees and Hartlepool, UK
1 shared publicationJohn Frater
Department of Paediatrics and Chemical Pathology, University Hospital of North Tees and Hartlepool, UK
1 shared publicationL Marriott
1 shared publication- Mainga Hamaluba
KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
1 shared publication Mohan Shenoy
Department of Paediatrics and Chemical Pathology, University Hospital of North Tees and Hartlepool, UK
1 shared publication
Latest Publications
- Open Access
- 1 December 2005
- Published by BMJ in Archives of Disease in Childhood
- Vol. 90 (12) , 1311-1312
Can transcutaneous bilirubinometry reduce the need for serum bilirubin estimations in term and near term infants?
A more sympathetic registrar gives you a recent review article1 on jaundice which indicates that the older generation bilirubinometers were shown to be inaccurate for clinical use; however, a newer version, the “SpectRx Bilicheck” may be more reliable. Bilicheck (BC) uses multiple wavelengths of light, and the manufacturer claims that the monitor is unaffected by skin pigmentation and other interfering factors.
- 1 December 2005
- Published by BMJ in Archives of Disease in Childhood
- Vol. 90 (12) , 1311-1312
Open AccessCan transcutaneous bilirubinometry reduce the need for serum bilirubin estimations in term and near term infants?
A more sympathetic registrar gives you a recent review article1 on jaundice which indicates that the older generation bilirubinometers were shown to be inaccurate for clinical use; however, a newer version, the “SpectRx Bilicheck” may be more reliable. Bilicheck (BC) uses multiple wavelengths of light, and the manufacturer claims that the monitor is unaffected by skin pigmentation and other interfering factors.
- 1 February 2005
- Published by Wiley in Acta Paediatrica
- Vol. 94 (2) , 155-158
Is procalcitonin useful in early diagnosis of serious bacterial infections in children?
To compare diagnostic accuracy of procalcitonin for early diagnosis of serious bacterial infection (SBI) in children presenting with fever and no focus of infection. Prospective, observational study involving 72 children (1-36 mo) presenting to the paediatric units of two university hospitals. All children had blood cultures, urine cultures, white blood cell counts (WBC), chest X-ray, C-reactive protein (CRP) and procalcitonin (PCT) done at presentation. Eight (11.1%) children had SBI (1 pneumonia, 2 meningitis, 4 septicaemia/occult bacteraemia, 2 pyelonephritis), 19 (26.4%) had possible bacterial infection (received antibiotic treatment, but no organism grown) and 45 (62.5%) had viral or possible viral infection (virus isolated and/or uneventful recovery without antibiotics). PCT (>2 ng/l), CRP (>50 mg/l) and McCarthy's score (50 mg/l), PCT (>2 ng/l), white blood cells (>15 x 10(5)/l) and McCarthy's score (<9) were 0.36/2.4, 0.58/3.5, 0.94/1.1 and 0.19/2.7, respectively. A combination of PCT, CRP and WBC generated a positive likelihood ratio of 10.6, changing the post-test probability to 54%. For early diagnosis of SBI in children presenting with fever and no focus of infection, the diagnostic utility of procalcitonin is similar to the traditional markers infection and clinical scoring. While a low procalcitonin level cannot be used to exclude SBI in this population, a combination of PCT, CRP and WBC may be more useful in predicting SBI.
- 1 February 2005
- Published by Wiley in Acta Paediatrica
- Vol. 94 (2) , 155-158
Is procalcitonin useful in early diagnosis of serious bacterial infections in children?
To compare diagnostic accuracy of procalcitonin for early diagnosis of serious bacterial infection (SBI) in children presenting with fever and no focus of infection. Prospective, observational study involving 72 children (1-36 mo) presenting to the paediatric units of two university hospitals. All children had blood cultures, urine cultures, white blood cell counts (WBC), chest X-ray, C-reactive protein (CRP) and procalcitonin (PCT) done at presentation. Eight (11.1%) children had SBI (1 pneumonia, 2 meningitis, 4 septicaemia/occult bacteraemia, 2 pyelonephritis), 19 (26.4%) had possible bacterial infection (received antibiotic treatment, but no organism grown) and 45 (62.5%) had viral or possible viral infection (virus isolated and/or uneventful recovery without antibiotics). PCT (>2 ng/l), CRP (>50 mg/l) and McCarthy's score (50 mg/l), PCT (>2 ng/l), white blood cells (>15 x 10(5)/l) and McCarthy's score (<9) were 0.36/2.4, 0.58/3.5, 0.94/1.1 and 0.19/2.7, respectively. A combination of PCT, CRP and WBC generated a positive likelihood ratio of 10.6, changing the post-test probability to 54%. For early diagnosis of SBI in children presenting with fever and no focus of infection, the diagnostic utility of procalcitonin is similar to the traditional markers infection and clinical scoring. While a low procalcitonin level cannot be used to exclude SBI in this population, a combination of PCT, CRP and WBC may be more useful in predicting SBI.